Acadia Pharmaceuticals Inc. (ACAD) Financials

Key financial figures for Acadia Pharmaceuticals Inc. (Q1 2026).

Revenue

$268M

Net Income

$4M

EPS

$0.02

Total Assets

$1.6B

Operating Cash Flow

$34M

Full income statement, balance sheet, and cash flow for Acadia Pharmaceuticals Inc. on SentiSense.